These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9377765)

  • 1. Primary transplant treatment of hepatitis B: hepatitis B immunoglobulin (passive immunization).
    Pruett T
    Liver Transpl Surg; 1997 Sep; 3(5 Suppl 1):S13-5. PubMed ID: 9377765
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of hepatitis B virus reinfection after liver transplantation.
    Rossi G; Grendele M; Colledan M; Gridelli B; Fassati LR; Maggi U; Reggiani P; Gatti S; Piazzini A; Lunghi G
    Transplant Proc; 1991 Jun; 23(3):1969. PubMed ID: 2063452
    [No Abstract]   [Full Text] [Related]  

  • 3. The questionable role of immunization against hepatitis B in HBV infected liver transplant patients.
    Samuel D; Shouval D
    J Hepatol; 2005 Aug; 43(2):203-6. PubMed ID: 15975686
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B immunoglobulin: new preparation. Prolongs survival after liver transplantation.
    Prescrire Int; 2003 Aug; 12(66):135-7. PubMed ID: 12906022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination. Hepatitis B].
    Braun R; Kimmig P; Hassler D
    Dtsch Med Wochenschr; 2002 May; 127(20):1062. PubMed ID: 12051190
    [No Abstract]   [Full Text] [Related]  

  • 6. Does antibody to hepatitis B surface antigen protect renal transplant patients from hepatitis B?
    Huo TI; Wu JC
    J Gastroenterol Hepatol; 2004 Aug; 19(8):841-3. PubMed ID: 15242483
    [No Abstract]   [Full Text] [Related]  

  • 7. [Active and passive immunization against hepatitis B virus infection].
    Colak H
    Mikrobiyol Bul; 1982 Jan; 16(1):71-6. PubMed ID: 7144619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term passive immunoprophylaxis of B virus recurrence after liver transplantation in HBs antigen-positive patients.
    Gugenheim J; Crafa F; Fabiani P; Goubaux B; Ouzan D; Mouiel J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1349-50. PubMed ID: 8442140
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term follow-up of hepatitis B virus infected patients after orthotopic liver transplantation].
    Theilmann L; Arnold JC
    Z Gastroenterol; 1995 Oct; 33(10):626-7. PubMed ID: 7502560
    [No Abstract]   [Full Text] [Related]  

  • 10. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspects of vaccination against hepatitis B; passive-active immunization schedules and vaccination responses in different age groups.
    Deinhardt F
    Scand J Infect Dis Suppl; 1983; 38():17-23. PubMed ID: 6580722
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.
    Ghany MG; Ayola B; Villamil FG; Gish RG; Rojter S; Vierling JM; Lok AS
    Hepatology; 1998 Jan; 27(1):213-22. PubMed ID: 9425940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlimited-term passive immunoprophylaxis after liver transplantation in HBsAg-positive patients.
    Lee SG; Lee YJ; Kwon TW; Park KM; Choi KM; Min PC; Chung YH; Lee YS
    Transplant Proc; 1996 Jun; 28(3):1176-7. PubMed ID: 8658617
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
    Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation.
    Protzer-Knolle U; Naumann U; Bartenschlager R; Berg T; Hopf U; Meyer zum Büschenfelde KH; Neuhaus P; Gerken G
    Hepatology; 1998 Jan; 27(1):254-63. PubMed ID: 9425945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heterogeneity of host response to hepatitis B virus].
    Sarno EN; Ruzany F; Vieira LM; Landmann J
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):303-9. PubMed ID: 7167709
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary evaluation of the effect of anti-HBs immunoglobulin used in medical personnel at high risk of infection with the hepatitis B virus].
    Kacperska E; Seyfried H; Poszwiński P; Komandowski R; Mordarski S
    Acta Haematol Pol; 1985; 16(1-2):21-6. PubMed ID: 3832739
    [No Abstract]   [Full Text] [Related]  

  • 18. Two-year study of passive-active immunization for prevention of hepatitis B infection in newborns.
    Theppisai U; Thanuntaseh C; Chiewsilp P; Siripoonya P
    J Med Assoc Thai; 1988 Aug; 71(8):413-6. PubMed ID: 2978040
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of chronic B virus hepatitis with specific transfer factor.
    Mazzella G; Ronchi M; Villanova N; Mohamed AA; Pizza G; De Vinci C; Viza D; Roda E; Barbara L
    J Exp Pathol; 1987; 3(4):421-3. PubMed ID: 3454802
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver transplantation for hepatitis B.
    Samuel D; Bismuth H
    Gastroenterol Clin North Am; 1993 Jun; 22(2):271-83. PubMed ID: 8509171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.